Therapy monitoring with FDG-PET in patients with metastatic colorectal cancer receiving FOLFOX chemotherapy.

被引：0
|
作者：
Dimitrakopoulou-Strauss, A
Rudi, J
Strauss, LG
机构：
[1] Univ Heidelberg, Med Clin, Heidelberg, Germany
[2] German Canc Res Ctr, D-6900 Heidelberg, Germany
来源：
JOURNAL OF NUCLEAR MEDICINE | 2000年 / 41卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
446
引用
收藏
页码：113P / 113P
页数：1
相关论文
共 50 条
  • [1] Therapy monitoring with FDG PET in patients with metastatic colorectal cancer receiving FOLFOX chemotherapy.
    Dimitrakopoulou-Strauss, A
    Strauss, L
    Rudi, J
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 22P - 23P
  • [2] Prognosis of therapy response with FDG-PET in metastatic colorectal carcinomas after FOLFOX chemotherapy
    Dimitrakopoulou-Strauss, A
    Rudi, J
    Burger, C
    Strauss, LG
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (08): : 961 - 961
  • [3] Multivariate prospective pharmacogenetic analysis in patients with resectable metastatic colorectal cancer (mCRC) receiving FOLFOX chemotherapy.
    Etienne-Grimaldi, Marie-Christine
    Hebbar, Mohamed
    De Gramont, Aimery
    Chibaudel, Benoist
    Andre, Thierry
    Formento, Patricia
    Llorca, Laurence
    Hadengue, Alexandra
    Mineur, Laurent
    Khalil, Ahmed
    Dutel, Jean Luc
    Ychou, Marc
    Mabro, May
    Smith, Denis Michel
    Faroux, Roger
    Brusquant, David
    Truant, Stephanie
    Paye, Francois
    Auby, Dominique
    Milano, Gerard
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [4] Chemotherapy response evaluation with FDG-PET in patients with colorectal cancer
    de Geus-Oei, L. F.
    van Laarhoven, H. W. M.
    Visser, E. P.
    Hermsen, R.
    van Hoorn, B. A.
    Kamm, Y. J. L.
    Krabbe, P. F. M.
    Corstens, F. H. M.
    Punt, C. J. A.
    Oyen, W. J. G.
    ANNALS OF ONCOLOGY, 2008, 19 (02) : 348 - 352
  • [5] Prognostic aspects of 18F-FDG PET kinetics in patients with metastatic colorectal carcinoma receiving FOLFOX chemotherapy
    Dimitrakopoulou-Strauss, A
    Strauss, LG
    Burger, C
    Rühl, A
    Irngartinger, G
    Stremmel, W
    Rudi, J
    JOURNAL OF NUCLEAR MEDICINE, 2004, 45 (09) : 1480 - 1487
  • [6] An evaluation of FDG-PET as a predictor of metabolic response to chemotherapy in metastatic colorectal cancer patients (mCRC).
    Van Damme, N.
    De Bruyne, S.
    Mertens, J.
    Van de Wiele, C.
    Ceelen, W. P.
    Smeets, P.
    Ferdinande, L.
    Laurent, S.
    Geboes, K.
    Peeters, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [7] FDG-PET imaging of residual testicular cancer after chemotherapy.
    Nuutinen, J
    Leskinen, S
    Elomaa, I
    Salminen, E
    Haaparanta, M
    Ruotsalainen, U
    Wegelius, U
    Minn, H
    Joensuu, H
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 1146 - 1146
  • [8] Serial FDG-PET/CT for early outcome prediction in patients with metastatic colorectal cancer undergoing chemotherapy
    Hendlisz, A.
    Golfinopoulos, V.
    Garcia, C.
    Emonts, P.
    Covas, A.
    Ameye, L.
    Paesmans, M.
    Deleporte, A.
    Machiels, G.
    Toussaint, E.
    Vanderlinden, B.
    Awada, A.
    Piccart, M.
    Flamen, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [9] Serial FDG-PET/CT for early outcome prediction in patients with metastatic colorectal cancer undergoing chemotherapy
    Hendlisz, A.
    Golfinopoulos, V.
    Garcia, C.
    Covas, A.
    Emonts, P.
    Ameye, L.
    Paesmans, M.
    Deleporte, A.
    Machiels, G.
    Toussaint, E.
    Vanderlinden, B.
    Awada, A.
    Piccart, M.
    Flamen, P.
    ANNALS OF ONCOLOGY, 2012, 23 (07) : 1687 - 1693
  • [10] FDG-PET in monitoring therapy of breast cancer
    H.-J. Biersack
    H. Bender
    H. Palmedo
    European Journal of Nuclear Medicine and Molecular Imaging, 2004, 31 : S112 - S117
12345